NVS presenter at FDA FoB panel says scheduling a pre-IND meeting with FDA to discuss an FoB takes an average of 6 months (!)—much longer than scheduling a pre-IND meeting for a novel drug.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”